About

Akos Czibere has served as Aktis Oncology's Chief Medical Officer since July 2024. From 2017 to 2024 he held roles of increasing responsibility at Pfizer, most recently as Vice President and Therapeutic Area Head of Hematology-Oncology, and earlier held senior positions at Merrimack Pharmaceuticals. He holds an MD and PhD from the University of Duesseldorf, Germany, and completed a postdoctoral fellowship at Harvard Medical School.

Roles

Aktis Oncology, Inc.
Chief Medical Officer · Current role
July 2024–present
Pfizer
Vice President, Therapeutic Area Head of Hematology-Oncology · Responsible for strategy and execution across multiple programs
April 2017 - July 2024
Merrimack Pharmaceuticals
Roles of increasing seniority

Fixed Compensation

FY 2025
Salary
$468,000
ComponentAnnual base salary earned in FY2025
All other compensation
$102,280
ComponentAll other compensation
Total compensation
$902,680

Performance Compensation

Data from FY 2025

Cash incentive

Nonequity incentive plan compensation
$106,650
Target Opportunity
PlanAnnual bonus program

Stock awards

Option awards
$225,750
FormOption awards, ASC 718 grant-date fair value

Also at Aktis Oncology, Inc.

Related

See how VectorShift works for your firm

Request Demo